Rossmore Private Capital’s Boston Scientific BSX Stock Holding History

Rossmore Private Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$525K	Buy	12,292 +4,090	+50%	+$222K	0.04%	208
2026 Q1	$515K	Hold	8,202	–	–	0.05%	201
2025 Q4	$782K	Buy	8,202 +2,223	+37%	+$218K	0.07%	163
2025 Q3	$584K	Hold	5,979	–	–	0.06%	174
2025 Q2	$642K	Hold	5,979	–	–	0.08%	164
2025 Q1	$603K	Buy	5,979 +71	+1%	+$7.15K	0.07%	160
2024 Q4	$528K	Sell	5,908 -45	-0.8%	-$3.96K	0.07%	164
2024 Q3	$499K	Hold	5,953	–	–	0.06%	169
2024 Q2	$458K	Buy	5,953 +72	+1%	+$5.27K	0.06%	171
2024 Q1	$403K	Buy	5,881 +66	+1%	+$4.24K	0.05%	187
2023 Q4	$336K	Hold	5,815	–	–	0.05%	190
2023 Q3	$307K	Sell	5,815 -105	-2%	-$5.51K	0.05%	189
2023 Q2	$320K	Sell	5,920 -63	-1%	-$3.29K	0.05%	191
2023 Q1	$299K	Hold	5,983	–	–	0.05%	192
2022 Q4	$277K	Buy	5,983 +168	+3%	+$7.28K	0.04%	198
2022 Q3	$225K	Hold	5,815	–	–	0.04%	205
2022 Q2	$217K	Hold	5,815	–	–	0.04%	210
2022 Q1	$258K	Hold	5,815	–	–	0.04%	203
2021 Q4	$247K	Hold	5,815	–	–	0.04%	209
2021 Q3	$252K	Hold	5,815	–	–	0.04%	201
2021 Q2	$249K	Hold	5,815	–	–	0.04%	196
2021 Q1	$225K	Hold	5,815	–	–	0.04%	200
2020 Q4	$209K	Hold	5,815	–	–	0.04%	193
2020 Q3	$222K	Hold	5,815	–	–	0.05%	180
2020 Q2	$204K	Buy	+5,815	New	+$209K	0.06%	163
2020 Q1	–	Sell	-5,815	Closed	-$263K	–	150
2019 Q4	$263K	Hold	5,815	–	–	0.08%	119
2019 Q3	$237K	Hold	5,815	–	–	0.08%	123
2019 Q2	$250K	Hold	5,815	–	–	0.09%	112
2019 Q1	$223K	Buy	+5,815	New	+$222K	0.08%	120
2018 Q1	–	Sell	-5,260	Closed	-$130K	–	143
2017 Q4	$130K	Buy	+5,260	New	+$145K	0.13%	114

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Rossmore Private Capital's BSX Position: Q2 2026 in Review

Rossmore Private Capital increased its Boston Scientific (BSX) stake by 50% in Q2 2026, buying an estimated $222K and bringing the position to 12,292 shares worth $525K. The position accounts for 0.04% of the portfolio, ranked #208.

Rossmore Private Capital first reported a position in BSX in Q4 2017 and has held it in 30 quarters since. The position peaked at $782K in Q4 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Rossmore Private Capital held 12,292 shares of Boston Scientific worth $525K as of Q2 2026.
Rossmore Private Capital bought 4,090 Boston Scientific shares in Q2 2026, an estimated $222K.
Boston Scientific made up 0.04% of Rossmore Private Capital's portfolio in Q2 2026, its #208 holding.
Rossmore Private Capital first reported a position in Boston Scientific in Q4 2017 and has held it in 30 quarters since.
Rossmore Private Capital's Boston Scientific position peaked at $782K in Q4 2025.
534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.